These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8943056)

  • 1. Ribonucleotide reductase R2 component is a novel malignancy determinant that cooperates with activated oncogenes to determine transformation and malignant potential.
    Fan H; Villegas C; Wright JA
    Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14036-40. PubMed ID: 8943056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mammalian ribonucleotide reductase R2 component cooperates with a variety of oncogenes in mechanisms of cellular transformation.
    Fan H; Villegas C; Huang A; Wright JA
    Cancer Res; 1998 Apr; 58(8):1650-3. PubMed ID: 9563477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The R1 component of mammalian ribonucleotide reductase has malignancy-suppressing activity as demonstrated by gene transfer experiments.
    Fan H; Huang A; Villegas C; Wright JA
    Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13181-6. PubMed ID: 9371820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribonucleotide reductase R2 gene expression and changes in drug sensitivity and genome stability.
    Huang A; Fan H; Taylor WR; Wright JA
    Cancer Res; 1997 Nov; 57(21):4876-81. PubMed ID: 9354452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in the cyclic AMP signal transduction pathway regulating ribonucleotide reductase gene expression in malignant H-ras transformed cell lines.
    Hurta RA; Wright JA
    J Cell Physiol; 1994 Jan; 158(1):187-97. PubMed ID: 7505277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A link between ferritin gene expression and ribonucleotide reductase R2 protein, as demonstrated by retroviral vector mediated stable expression of R2 cDNA.
    Fan H; Villegas C; Wright JA
    FEBS Lett; 1996 Mar; 382(1-2):145-8. PubMed ID: 8612737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of malignancy by the 3' untranslated regions of ribonucleotide reductase R1 and R2 messenger RNAs.
    Fan H; Villegas C; Huang A; Wright JA
    Cancer Res; 1996 Oct; 56(19):4366-9. PubMed ID: 8813126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant transformation by H-ras results in aberrant regulation of ribonucleotide reductase gene expression by transforming growth factor-beta 1.
    Hurta RA; Wright JA
    J Cell Biochem; 1995 Mar; 57(3):543-56. PubMed ID: 7768988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early induction of ribonucleotide reductase gene expression by transforming growth factor beta 1 in malignant H-ras transformed cell lines.
    Hurta RA; Samuel SK; Greenberg AH; Wright JA
    J Biol Chem; 1991 Dec; 266(35):24097-100. PubMed ID: 1748682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the Raf-1/MAP kinase cascade is not sufficient for Ras transformation of RIE-1 epithelial cells.
    Oldham SM; Clark GJ; Gangarosa LM; Coffey RJ; Der CJ
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):6924-8. PubMed ID: 8692920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation.
    Khosravi-Far R; White MA; Westwick JK; Solski PA; Chrzanowska-Wodnicka M; Van Aelst L; Wigler MH; Der CJ
    Mol Cell Biol; 1996 Jul; 16(7):3923-33. PubMed ID: 8668210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SCH 51344 inhibits ras transformation by a novel mechanism.
    Kumar CC; Prorock-Rogers C; Kelly J; Dong Z; Lin JJ; Armstrong L; Kung HF; Weber MJ; Afonso A
    Cancer Res; 1995 Nov; 55(21):5106-17. PubMed ID: 7585559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of mitogen-activated protein kinases and c-Jun/AP-1 trans-activating activity in the regulation of protease mRNAs and the malignant phenotype in NIH 3T3 fibroblasts.
    Janulis M; Silberman S; Ambegaokar A; Gutkind JS; Schultz RM
    J Biol Chem; 1999 Jan; 274(2):801-13. PubMed ID: 9873019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of the Ras suppressor Rsu-1 enhances Erk-2 activation and inhibits Jun kinase activation.
    Masuelli L; Cutler ML
    Mol Cell Biol; 1996 Oct; 16(10):5466-76. PubMed ID: 8816460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta 1 mediated alterations in ribonucleotide reductase gene expression in BALB/c 3T3 fibroblasts.
    Hurta RA; Greenberg AH; Wright JA
    J Cell Physiol; 1992 Sep; 152(3):529-35. PubMed ID: 1506411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinase-deficient Pak1 mutants inhibit Ras transformation of Rat-1 fibroblasts.
    Tang Y; Chen Z; Ambrose D; Liu J; Gibbs JB; Chernoff J; Field J
    Mol Cell Biol; 1997 Aug; 17(8):4454-64. PubMed ID: 9234703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining a novel cis element in the 3'-untranslated region of mammalian ribonucleotide reductase component R2 mRNA: role in transforming growth factor-beta 1 induced mRNA stabilization.
    Amara FM; Chen FY; Wright JA
    Nucleic Acids Res; 1995 May; 23(9):1461-7. PubMed ID: 7784197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid induction of heparin-binding epidermal growth factor/diphtheria toxin receptor expression by Raf and Ras oncogenes.
    McCarthy SA; Samuels ML; Pritchard CA; Abraham JA; McMahon M
    Genes Dev; 1995 Aug; 9(16):1953-64. PubMed ID: 7649477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in the activity and regulation of mammalian ribonucleotide reductase by chlorambucil, a DNA damaging agent.
    Hurta RA; Wright JA
    J Biol Chem; 1992 Apr; 267(10):7066-71. PubMed ID: 1551913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.